Clinicopathologic analysis of CD10+ and CD10- diffuse large B-cell lymphoma: Identification of a high-risk subset with coexpression of CD10 and bcl-2

American Journal of Clinical Pathology

Volumn 116, Issue 2, 2001, Pages 183-190

  Xu, Y ^a   McKenna, R W ^a   Molberg, K H ^a   Kroft, S H ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

bcl 2; CD10; Diffuse large B cell lymphema; Lymphoma

Indexed keywords

COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; PROTEIN BCL 2; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER REGRESSION; CANCER SURVIVAL; CHILD; CLINICAL FEATURE; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; MIDDLE AGED; NEPRILYSIN; PROTO-ONCOGENE PROTEINS C-BCL-2; REMISSION INDUCTION; SURVIVAL RATE;

EID: 0034757162     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/J7RN-UXAY-55GX-BUNK     Document Type: Article

References (44)

1. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
2. The non-Hodgkin's lymphoma classification project: A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma
3. Subclassification of diffuse B-cell lymphomas according to the Kiel classification: Distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factor
4. National Cancer Institute sponsored study of classification of non-Hodgkin's lymphomas: Summary and description of a Working Formation for clinical usage
5. Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas: Results of a prospective multicenter study by the Kiel Lymphoma Study Group
6. The clinical significance of the morphological subdivision of diffuse "histocytic" lymphoma: A study of 162 patients treated by the Southwest Oncology Group
7. Clinical significance of morphologic subdivision in diffuse large cell lymphoma
8. Diffuse large B-cell lymphoma: Is morphologic subdivision useful in clinical management?
9. Common acute lymphocytic leukemia antigen is identical to neutral endopeptidase
10. Hematopoietic differentiation antigens that are membrane-associated enzymes: Cutting is the key!
11. The common acute lymphoblastic leukemia antigen (CD-10): Emancipation from a functional enigma
12. CD10 expression in follicular lymphoma and large cell lymphoma is different from that of reactive lymph node follicles
13. Identification of a subset of normal B cells with a Burkitt's lymphoma (BL)-like phenotype
14. Phenotypic expression of B-lymphocytes, 1: Identification with monoclonal antibodies in normal lymphoid tissues
15. Anatomical distribution of call antigen expressing cells in normal lymphatic tissue and in lymphomas
16. Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18
17. Incidence and prognostic significance of t(14;18) translocation in follicular center cell lymphoma of low and high grade
18. Small noncleaved cell lymphoma: An immunophenotypic study of 18 cases and comparison with large cell lymphoma
19. A monoclonal antibody to human acute lymphoblastic leukaemia antigen
20. CD10 antigen expression correlates with the t(14;18)(q32;q21) major breakpoint region in diffuse large B-cell lymphoma
21. Prognostic significance of bcl-2 protein expression and bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma
22. Prognostic significance of bcl-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: A British National Lymphoma Investigation study
23. Bcl-6 and bcl-2 protein expression in diffuse large B-cell lymphoma and follicular lymphoma: Correlation with 3q27 and 18q21 chromosomal abnormalities
24. Clinical relevance of bcl2, bcl6, and MYC rearrangements in diffuse large B-cell lymphoma
25. Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma
26. Bcl-2 initiates a new category of oncogenes: Regulator of cell death
27. Clinical significance of Bcl2 and p53 protein expression in diffuse large B-cell lymphoma: A population-based study
28. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line
29. Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death
30. Constitutive expression of human bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis
31. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18)
32. EORTC classification for primary cutaneous lymphomas: A proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer
33. Lymphocytic lymphornas
34. Similar outcome of treatment of B-cell and T-cell diffuse large-cell lymphomas: The Stanford experience
35. The international non-Hodgkin's lymphoma prognostic factors project: A predictive model for aggressive non-Hodgkin's lymphoma
36. Molecular and immunological dissection of diffuse large B cell lymphoma: CD5+, and CD50- with CD10+ groups may constitute clinically relevant subtypes
37. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
38. The clinical significance of CD10 antigen expression in diffuse large B-cell lymphoma
39. De novo CD5-positive diffuse large B-cell lymphoma: Clinical characteristics and therapeutic outcome
40. Immunohistochemical detection of CD10 with monoclonal antibody 56C6 on paraffin sections
41. Anti-CD10 immunoperoxidase staining of paraffin-embedded acute leukemias: Comparison with flow cytometric immunophenotyping
42. Comparison of immunohistochemistry and flow cytometry with cluster analysis for the detection of CD10
43. Bcl2 overexpression associated with chromosomal amplification in diffuse large B-cell lymphoma
44. Bcl2 overexpression in diffuse large B-cell lymphoma